Fujirebio Europe

Fujirebio Europe is owned by HU Group Holdings.

HU Group Holdings is one of the...

• Topix.

HU Group Holdings is a company listed under the stock ticker 4544 (JP).

HU Group Holdings has a direct presence in 4 countries.

HU Group Holdings has 5 subsidiaries including Fujirebio, Fujirebio Diagnostics and Fujirebio Diagnostics Europe.

They are in:

• Biotechnology33%
• Medical Equipment33%
• Other33%

View the org chart displaying its 8 main executives

Most searched biographies at Fujirebio Europe

• Christiaan De Wilde, Chief Executive Officer
• Kris D'Hoey, Chief Financial Officer
• Richard Van Maanen, Vice President of Business Development

Create your alert
to follow the executive moves at Fujirebio Europe.

HU Group Holdings has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Fujirebio Europe

Social media about Fujirebio Europe

• Fujirebio Europe on Wikipedia, Google News & Yahoo Finance
• Fujirebio Europe on LinkedIn, Twitter & YouTube

Contact by email its executives including Kris D'Hoey

Call Fujirebio Europe at +32 ...

View the org chart

Register to receive your alert

Report an error